Clinical Trial Update: Bevacizumab and Photodynamic Therapy in Neovascular Age Related Macular Degeneration [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bevacizumab in combination with photodynamic therapy for neovascular age-related macular degeneration was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Neovascular Age-related Macular Degeneration

Drugs mentioned

• Bevacizumab (bevacizumab)
• Verteporfin (verteporfin)

Snippet

Sponsor: Asociación para Evitar la Ceguera en México | Conditions: Age Related Macular Degeneration | Phase 2 | Status: TERMINATED